The Center for Technology Licensing's (CTL) mission is to bring the University's scientific discoveries, technological innovations, and medical advances to the marketplace for societal benefit and to foster economic development within New York State and across the nation.
Licensing
CTL is industry's link to Cornell's broad range of innovative research that is available for licensing. Over the years, Cornell technologies have been licensed to industry partners all over the world in support of Cornell's land-grant mission and to develop these technologies and plant varieties into products and services for public good.
Available Cornell Technologies
- REX Profiling For Identifying Druggable Targets
- Novel Biopesticide Against Agricultural Pests
- Use of Recombinant Cytokine-Antigen Fusion Proteins to Improve Serological Assays
- Improved Methods Using Mass Spectrometry to Identify Cross-links in Proteins
- CANFI: Continuous Additive Nanomanufacturing at Fluid Interfaces
- Pre-Compression to Enhance Foam Actuator Performance
Current Featured Technologies
- » Red Wine Grape ‘Arandell’
- » Generic Programmable Tag
- » White Wine Grape ‘Aromella’
- » Tethered Enzyme Technology (TET™) Point-of-Care Testing for Brain Injuries
- » Accommodating Intraocular Lens & Conversion Plate
- » Biomarkers for Predicting & Diagnosing Cancer/Metastasis
- » Reversible Small Molecule Immunoproteasome Inhibitors